Carrie Strom

Senior Vice President, AbbVie, and President, Global Allergan Aesthetics

Carrie Strom is Senior Vice President, AbbVie, and President, Global Allergan Aesthetics and has served in this role since May 2020.

Prior to joining AbbVie, Carrie served as Senior Vice President of U.S. Medical Aesthetics at Allergan Aesthetics beginning in May 2018, overseeing the aesthetic portfolio for the multi-billion dollar U.S. business including the iconic brand BOTOX® (botulinum toxin Type A), the JUVÉDERM® Collection of Fillers, BELKYRA® (deoxycholic acid injection), COOLSCULPTING®, COOLTONE™, SKINMEDICA®, LATISSE® (bimatoprost ophthalmic solution), NATRELLE® Implants and accessories, BRSTTM Implants, KELLER FUNNEL®2, REVOLVE™ Advanced Adipose System along with the regenerative medicine portfolio that includes ALLODERM™ Regenerative Tissue Matrix and STRATTICE™ Reconstructive Tissue Matrix.  This is a statement regarding the global business.  Not all brands are available in Australia and New Zealand.
Previously, Carrie was Vice President of Marketing, Plastic Surgery and Regenerative Medicine at Allergan from June 2016. 2017 posted a record-high growth rate, where she was instrumental in the $2.8B acquisition and integration of LifeCell. Prior to that, Carrie led SKINMEDICA® Marketing from 2014 and worked on BOTOX® therapeutic at Allergan from 2011. 

Before Allergan, Carrie spent over 10 years at Pfizer where she led marketing for Lipitor® and held various other sales and marketing roles.

Carrie received a B.A. in Communications from the University of Colorado, Boulder. She is an advocate for women in business and is actively involved with the Girls Inc. organisation. She serves on the board of directors for Susan G. Komen of Orange County, CA and as a board observer for HintMD. Carrie lives in Newport Beach, CA with her husband and two children.

AU-NON-2050121 V1 DoP: May 2021